12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma

Cancer Genetics

Volumn 205, Issue 6, 2012, Pages 332-336

  Kyriazoglou, Anastasios I ^a   Vieira, Joana ^b   Dimitriadis, Efthimios ^a   Arnogiannaki, Niki ^a   Teixeira, Manuel R ^b,c   Pandis, Nikos ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

12q amplification; CGH; Cytogenetics; Low grade extraskeletal osteosarcoma; MDM2 and CDK4 amplification

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2; CDK4 PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; CDK4 GENE; CHROMOSOME 12Q; CHROMOSOME G BAND; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE FREE SURVIVAL; EXTRASKELETAL OSTEOSARCOMA; GENE; GENETIC ANALYSIS; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JUXTACORTICAL OSTEOSARCOMA; MALE; MARKER CHROMOSOME; MDM2 GENE; METASTASIS FREE SURVIVAL; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RING CHROMOSOME; TELOMERE; ADJUVANT THERAPY; BONE TUMOR; CHROMOSOME 12; CHROMOSOME BANDING PATTERN; GENE AMPLIFICATION; GENETICS; PATHOLOGY; PROGNOSIS;

ADULT; BONE NEOPLASMS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 12; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN-DEPENDENT KINASE 4; GENE AMPLIFICATION; HUMANS; MALE; OSTEOSARCOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; RADIOTHERAPY, ADJUVANT; REAL-TIME POLYMERASE CHAIN REACTION; RING CHROMOSOMES; TELOMERE;

EID: 84865845991     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.04.011     Document Type: Article

References (28)

1. Rosenberg A.E., Heim S. Extraskeletal osteosarcoma. World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone 2002, IARC Press, Lyon. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
2. Rosenberg Z.S., Lev S., Schmahmann S., et al. Osteosarcoma: subtle, rare, and misleading plain film features. AJR Am J Roentgenol 1995, 165:1209-1214.
3. Mohamed A.N., Zalupski M.M., Ryan J.R., et al. Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group Study. Cancer Genet Cytogenet 1997, 99:45-53.
4. Mertens F., Fletcher C.D., Dal Cin P., et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer 1998, 22:16-25.
5. Mandahl N., Heim S., Willen H., et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer 1989, 1:9-14.
6. Mandahl N., Gustafson P., Mertens F., et al. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer 2002, 33:188-200.
7. ISCN 2009: an international system for human cytogenetic nomenclature 2009, Karger, Basel. L.G. Schaffer, M.L. Slovak, L.J. Campbell (Eds.).
8. Teixeira M.R., Ribeiro F.R., Torres L., et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer 2004, 91:775-782.
9. Gisselsson D., Pettersson L., Hoglund M., et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A 2000, 97:5357-5362.
10. Lau C.C., Harris C.P., Lu X.Y., et al. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004, 39:11-21.
11. Man T.K., Lu X.Y., Jaeweon K., et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 2004, 4:45.
12. Sandberg A.A., Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet 2003, 143:1-31.
13. Selvarajah S., Yoshimoto M., Maire G., et al. Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet 2007, 179:52-61.
14. van Dartel M., Hulsebos T.J. Amplification and overexpression of genes in 17p11.2 ∼ p12 in osteosarcoma. Cancer Genet Cytogenet 2004, 153:77-80.
15. Grubb G., Hoctor V., Venter D., et al. Inversion (6)(p23q15) as the sole anomaly in a low-grade intraosseous osteosarcoma. Cancer Genet Cytogenet 1999, 109:70-71.
16. Swarts S.J., Neff J.R., Nelson M., et al. Chromosomal abnormalities in low grade chondrosarcoma and a review of the literature. Cancer Genet Cytogenet 1997, 98:126-130.
17. Italiano A., Bianchini L., Gjernes E., et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res 2009, 15:5696-5703.
18. Wunder J.S., Eppert K., Burrow S.R., et al. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 1999, 18:783-788.
19. Schmidt H., Taubert H., Wurl P., et al. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes Cancer 2002, 34:69-77.
20. Mejia-Guerrero S., Quejada M., Gokgoz N., et al. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer 2010, 49:518-525.
21. Forus A., Larramendy M.L., Meza-Zepeda L.A., et al. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genet Cytogenet 2001, 125:100-111.
22. Umiker W., Jaffe H.L. Ossifying fibrosarcoma (extraskeletal osteogenic sarcoma) of thigh muscle; report of a case with recurrence and widespread metastases more than four and a half years after excision. Ann Surg 1953, 138:795-800.
23. Present D., Bertoni F., Laus M., et al. Case report 565: low-grade osteosarcoma of soft tissues (popliteal fossa). Skeletal Radiol 1989, 18:471-474.
24. Yi E.S., Shmookler B.M., Malawer M.M., et al. Well-differentiated extraskeletal osteosarcoma. A soft-tissue homologue of parosteal osteosarcoma. Arch Pathol Lab Med 1991, 115:906-909.
25. Okada K., Ito H., Miyakoshi N., et al. A low-grade extraskeletal osteosarcoma. Skeletal Radiol 2003, 32:165-169.
26. Abramovici L.C., Hytiroglou P., Klein R.M., et al. Well-differentiated extraskeletal osteosarcoma: report of 2 cases, 1 with dedifferentiation. Hum Pathol 2005, 36:439-443.
27. Sabatier R., Bouvier C., de Pinieux G., et al. Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature. BMC Cancer 2010, 10:645.
28. Klein M.J., Siegal G.P. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 2006, 125:555-581.